Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket

Published 15/12/2023, 13:17
© Reuters.  Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results.

Getaround posted a quarterly loss of 29 cents per share, versus a year-ago loss of $1.3 per share. The company’s sales came in at $23.80 million, up from $16.74 million in the year-earlier quarter.

Getaround shares jumped 86.1% to $0.3071 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Brilliant Acquisition Corporation (NASDAQ: BRLI) shares gained 71.8% to $11.00 in pre-market trading.
  • Near Intelligence, Inc. (NASDAQ: NIR) gained 36.4% to $0.1006 in pre-market trading after gaining over 5% on Thursday.
  • Chavant Capital Acquisition Corp. (NASDAQ: CLAY) shares gained 31.4% to $14.61 in pre-market trading. Mobix Labs, Inc. and Chavant Capital Acquisition Corp. announced effectiveness of registration statement on Form S-4.
  • i-80 Gold Corp. (NYSE: IAUX) shares climbed 27.2% to $2.20 in pre-market trading after surging over 10% on Thursday.
  • Netcapital Inc. (NASDAQ: NCPL) shares rose 27.2% to $0.4407 in pre-market trading following second-quarter results.
  • Heart Test Laboratories, Inc. (NASDAQ: HSCS) gained 20.8% to $0.19 in pre-market trading following second-quarter results.
  • Solo Brands, Inc. (NYSE: DTC) gained 17.3% to $6.50 in pre-market trading.
  • Assure Holdings Corp. (NASDAQ: IONM) shares surged 16.2% to $0.42 in pre-market trading after falling 9% on Thursday.
  • Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) rose 10% to $0.2850 in pre-market trading after falling 35% on Thursday.
Losers
  • Aadi Bioscience, Inc. (NASDAQ: AADI) shares fell 45.3% to $2.94 in pre-market trading after the company reported interim results from PRECISION1 trial of nab-sirolimus demonstrating anti-tumor activity in solid tumors with TSC1 or TSC2 inactivating alterations.
  • Lufax Holding Ltd (NYSE: LU) shares fell 44.5% to $2.11 in pre-market trading.
  • Inno Holdings Inc. (NASDAQ: INHD) shares fell 36.4% to $8.82 in pre-market trading after jumping over 246% on Thursday. The company priced its IPO at $4 per share.
  • Mangoceuticals, Inc. (NASDAQ: MGRX) fell 35.4% to $0.3360 in pre-market trading after declining around 10% on Thursday.
  • Palatin Technologies, Inc. (NYSE: PTN) shares fell 26.1% to $1.95 in pre-market trading.
  • Aileron Therapeutics, Inc. (NASDAQ: ALRN) shares fell 20.5% to $4.27 in pre-market trading after jumping 115% on Thursday.
  • Freight Technologies, Inc. (NASDAQ: FRGT) fell 19.8% to $0.4804 in pre-market trading. Freight Technologies shares jumped 122% on Thursday after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions.
  • Eos Energy Enterprises, Inc. (NASDAQ: EOSE) fell 19.5% to $1.35 in pre-market after the company reported pricing of $50 million public offering.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares fell 17% to $0.8549 in pre-market trading. Ensysce Biosciences recently announced a recent study demonstrating efficacy data for PF614.
  • Scholastic Corporation (NASDAQ: SCHL) fell 12.6% to $36.20 in pre-market trading after the company posted weaker-than-expected results for its second quarter. The company’s board also approved an additional $66 million for share repurchases.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Fear & Greed Index Remains In 'Greed' Zone Following Economic Reports; Dow Records New High

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.